While much attention has classically been devoted to analyzing p-Tau in AD and other tauopathies, the role of p-Tau in non-AD states has been largely neglected, partly due to a broad misconception that Tau toxicity only occurs when a large number of epitopes are hyperphosphorylated. Here, MAPT is linked to Alzheimer disease.